Research programme: tenofovir bisphosphonamidates - Gilead Sciences
Alternative Names: Tenofovir bisphosphonamidates research programme - Gilead SciencesLatest Information Update: 22 Apr 2003
At a glance
- Originator Gilead Sciences
- Class
- Mechanism of Action RNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 21 Apr 2001 New profile
- 21 Apr 2001 Preclinical development for HIV infections treatment in USA (PO)